Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
9.41M
-
Shares change
-
-855K
-
Total reported value, excl. options
-
$20.4M
-
Value change
-
-$1.89M
-
Put/Call ratio
-
2.14
-
Number of buys
-
19
-
Number of sells
-
-33
-
Price
-
$2.17
Significant Holders of GALECTIN THERAPEUTICS INC - COM NEW (GALT) as of Q1 2021
84 filings reported holding GALT - GALECTIN THERAPEUTICS INC - COM NEW as of Q1 2021.
GALECTIN THERAPEUTICS INC - COM NEW (GALT) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.41M shares
.
Largest 10 shareholders include BlackRock Inc. (2.62M shares), VANGUARD GROUP INC (1.93M shares), ADVISOR GROUP HOLDINGS, INC. (1.22M shares), GEODE CAPITAL MANAGEMENT, LLC (646K shares), STATE STREET CORP (615K shares), NORTHERN TRUST CORP (421K shares), RENAISSANCE TECHNOLOGIES LLC (307K shares), Cutter & CO Brokerage, Inc. (185K shares), Nuveen Asset Management, LLC (177K shares), and JPMORGAN CHASE & CO (101K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.